Blog

Petros Grivas: Phenomenal Bladder Cancer Advocacy Network

Photo taken from Petros Grivas/X

Aug 11, 2024, 15:57

Petros Grivas: Phenomenal Bladder Cancer Advocacy Network

Petros Grivas shared a post a post on X by Shilpa Gupta:

“Phenomenal Bladder Cancer Advocacy Network BCANTT24 congrats to SC team (we had fun working together this past year), thanks Stephanie Chisolm, Rebecca Johnson and all the staff, co-chairs Shilpa Gupta, Eugene Pietzak
patients, advocates, speakers, attendees et al.

I always leave so energized & inspired.“

Quoting Shilpa Gupta’s post:

“What an amazing BCANTT24 it was.

Thx Eugene Pietzak, Stephanie Chisolm, Rebecca Johnson, SC members, co-chairs, speakers, pt advocates & attendees for a fantastic meeting.

It was all about patients from beginning to end! Looking forward to working w/ Max Kates for planning BCANTT25“

Source: Petros Grivas/X and Shilpa Gupta/X

Dr. Petros Grivas, a board-certified medical oncologist, serves as Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance. He’s an Associate Professor at the Dept. of Medicine and Associate Member at Fred Hutchinson Cancer Research Center since January 2018. With extensive training and experience, he’s led clinical trials, contributing to FDA approvals for bladder/urothelial cancer treatments.

Dr. Shilpa Gupta is the Director of Genitourinary Oncology, a staff member in Hematology and Oncology and a Professor of Medicine at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.

More about BCANTT24: The annual BCAN Bladder Cancer Think Tank Meeting is the premier annual bladder cancer-specific medical meeting in North America.

The Think Tank fosters innovation and collaboration among individuals from the medical, research, and patient communities. Its objective is to accelerate advancements in diagnosing, treating, and enhancing the quality of life for those affected by bladder cancer.

Since its establishment in 2006, the Think Tank meeting has focused on identifying obstacles and creating solutions in bladder cancer research, and has fostered discussions to help define priorities for advancing bladder cancer research.

The invited participants comprise urologists, oncologists, researchers, pathologists, social scientists, patient advocates, and industry representatives, all committed to advancing the diagnosis and treatment of bladder cancer.

BCANTT24 Bladder Cancer Advocacy Network cancer Eugene Pietzak Max Kates OncoDaily Oncology Petros Grivas Rebecca Johnson Shilpa Gupta Stephanie Chisolm

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage